← Back to Clinical Trials
RecruitingNCT06723795

Cardiovascular Assessment and Treatment During COPD Exacerbation to Improve Diagnosis and Outcomes

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

ConditionCOPD (Chronic Obstructive Pulmonary Disease)
SponsorTel-Aviv Sourasky Medical Center
Study TypeINTERVENTIONAL
PhaseN/A
Enrollment150
SexALL
Min Age18 Years
Max Age75 Years
Start Date2025-03-01
Completion2027-03-01
Interventions
Cardiologist evaluationPulmonologist evaluation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This is a research study involving patients hospitalized for COPD flare-ups. Patients will be randomly assigned to two groups: one group will only see a pulmonologist (lung doctor), and the other group will also be seen by a cardiologist (heart doctor) during their hospital stay. Both groups will fill out a questionnaire, and the pulmonologist will review their lung disease, adjust their treatment, and recommend follow-up care. The cardiologist will also assess the second group for heart diseases (like high cholesterol, diabetes, heart disease, high blood pressure, or heart failure) and start or adjust heart treatment if needed. Both groups will be followed up by phone 1, 3, 6 and 12 months later to check for changes in treatment, new heart problems, COPD flare-ups, or death.

Eligibility Criteria

Inclusion Criteria: * Documented COPD (based on lung function tests, symptoms and relevant treatment). * Aged 18-75 years. * Mentally competent to understand and follow medical recommendations. Exclusion Criteria: * Under 18 years of age. * Unable to provide consent. * Unstable concurrent disease.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology